Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease that is associated with
mutations in tuberous sclerosis genes, renal angiomyolipomas, lymphatic spread, and …

Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders.
Unfortunately, due to post–lung transplant complications, both infectious and noninfectious …

Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that
is associated with poor survival. The International Society for Heart and Lung …

BACKGROUND: Because the development of donor-specific anti-human leukocyte antigen
(HLA) antibodies (DSA) after lung transplantation has been associated with acute and …

BACKGROUND Lung transplant (LTx) recipients have low long-term survival and a high
incidence of bronchiolitis obliterans syndrome (BOS). However, few long-term, multicenter …

Multiple infections have been linked with the development of bronchiolitis obliterans
syndrome (BOS) post-lung transplantation. Lung allograft airway colonization by Aspergillus …

Starting about 60 years ago, a number of reports appeared that outlined the severe clinical
course of a few adult subjects with profound hypogammaglobinemia. Puzzled by the lack of …

Background Idiopathic pulmonary fibrosis (IPF) is a distinct form of interstitial pneumonia
with unknown origin and poor prognosis. Current pharmacologic treatments are limited and …

Background Bronchiolitis obliterans syndrome (BOS) is the major cause of late graft failure
after lung transplantation. The objective was to determine whether de novo donor human …

Rationale: Despite the importance of bronchiolitis obliterans syndrome (BOS) in lung
transplantation, little is known regarding the factors that influence survival after the onset of …